Fundraising Fox

Amylyx

2 known investors

Amylyx is a biopharmaceutical company developing novel therapies for diseases with high unmet medical needs. It focuses on solving difficult medical challenges for affected patients and their families.

BiotechHealthtech

Founders & leadership

JCJoshua Cohen
Joshua CoheninCo-Founder and Co-CEO at Amylyx Pharmaceuticals

Investors · 2

Alpha Wave GlobalMiami
Avoro Capital AdvisorsNew York

In the news

Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week | The Motley Foolfool.com · Aug 2026Amylyx Raises $500 Million to Advance Avexitide After Positive Phase 3 PBH Results | BioPharm Internationalbiopharminternational.com · Aug 2026Guggenheim raises Amylyx stock price target on trial results By Investing.cominvesting.com · Aug 2026Amylyx Pharmaceuticals (AMLX) Posts Phase 3 Avexitide Win And Follows With Equity Raisefinance.yahoo.com · Aug 2026Amylyx moves to raise USD 350m after avexitide's Phase III hypoglycemia winallsci.com · Aug 2026

Frequently asked questions

What does Amylyx do?
Amylyx is a biopharmaceutical company developing novel therapies for diseases with high unmet medical needs. It focuses on solving difficult medical challenges for affected patients and their families.
Who founded Amylyx?
Amylyx was founded by Joshua Cohen.
Who are Amylyx's investors?
Amylyx's investors include Alpha Wave Global, Avoro Capital Advisors.